Peripheral muscle dysfunction in patients with COPD: Comparing apples to apples?

Chest

Volumn 124, Issue 1, 2003, Pages 1-4

  Sue, Darryl Y ^a,b  

^a HARBOR UCLA MEDICAL CENTER   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROCORTISONE; INTERLEUKIN 6; OXYGEN; PRASTERONE; SOMATOMEDIN; TESTOSTERONE;

ANTHROPOMETRY; BIOSYNTHESIS; BREATHING; CATABOLISM; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMPUTER ASSISTED TOMOGRAPHY; CORRELATION ANALYSIS; DISEASE SEVERITY; EDITORIAL; HUMAN; INFLAMMATION; MULTIPLE REGRESSION; MUSCLE ATROPHY; MUSCLE MASS; MUSCLE STRENGTH; MYOPATHY; OUTPATIENT; OUTPATIENT DEPARTMENT; OXYGEN TENSION; POPULATION RESEARCH; PRESSURE; PREVALENCE; PRIORITY JOURNAL; RANDOMIZATION; SEX RATIO; STATISTICAL SIGNIFICANCE; SURVIVAL RATE; THIGH;

EID: 0037485457     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.124.1.1     Document Type: Editorial

References (16)

1. Gosselink R, Troosters T, Decramer M. Peripheral muscle weakness contributes to exercise limitation in COPD. Am J Respir Crit Care Med 1996; 153:976-980
2. Killian KJ, Leblanc P, Martin DH, et al. Exercise capacity and ventilatory, circulatory, and symptom limitation in patients with chronic airflow limitation. Am Rev Respir Dis 1992; 146:935-940
3. O'Donnell DE, Revill SM, Webb KA. Dynamic hyperinflation and exercise intolerance in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2001; 164:770-777
4. American Thoracic Society/European Respiratory Society. Skeletal muscle dysfunction in chronic obstructive pulmonary disease: a statement of the American Thoracic Society and European Respiratory Society. Am J Respir Crit Care Med 1999; 159:S1-S40
5. Casaburi R. Skeletal muscle function in COPD. Chest 2000; 117(suppl):267S-271S
6. Debigaré R, Coté CH, Maltais F. Peripheral muscle wasting in chronic obstructive pulmonary disease: clinical relevance and mechanisms. Am J Respir Crit Care Med 2001; 164:1712-1717
7. Marquis K, Debigaré R, Lacasse Y, et al. Midthigh muscle cross-sectional area is better predictor of mortality than body mass index in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2002; 166:809-813
8. Casaburi R, Porszasz J, Burns MR, et al. Physiologic benefits of exercise training in rehabilitation of patients with severe chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1997; 155:1541-1551
9. Somfay A, Porszasz J, Lee SM, et al. Effect of hyperoxia on gas exchange and lactate kinetics following exercise onset in nonhypoxemic COPD patients. Chest 2002; 121:393-400
10. 2 kinetics during exercise in obstructive pulmonary disease. J Appl Physiol 1995; 78:2228-2234
11. Bernard S, LeBlanc P, Whittom F, et al. Peripheral muscle weakness in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1998; 158:629-634
12. Engelen MP, Schols AM, Does JD, et al. Skeletal muscle weakness is associated with wasting of extremity fat-free mass but not with airflow obstruction in patients with chronic obstructive pulmonary disease. Am J Clin Nutr 2000; 71:733-738
13. Gosker HR, Engelen MPKJ, van Mameren H, et al. Muscle fiber type IIX atrophy is involved in the loss of fat-free mass in chronic obstructive pulmonary disease. Am J Clin Nutr 2002; 76:113-119
14. Schols AM, Buurman WA, Staal van den Brekel AJ, et al. Evidence for a relation between metabolic derangements and increased levels of inflammatory mediators in a subgroup of patients with chronic obstructive pulmonary disease. Thorax 1996; 51:819-824
15. Vogiatzis I, Williamson AF, Miles J, et al. Physiological response to moderate exercise workloads in a pulmonary rehabilitation program in patients with varying degrees of airflow obstruction. Chest 1999; 116:1200-1207
16. Lacasse Y, Brosseau L, Milne S, et al. Pulmonary rehabilitation for chronic obstructive pulmonary disease (Cochrane review). Cochrane Library, issue 1, 2003. Oxford, UK: Update Software, 2003